News & Opinion

» opinion and techniques

Covering the life sciences inside and out

Most Recent

image: Next Generation: The Heart Camera

Next Generation: The Heart Camera

By | June 19, 2012

A new camera system allows researchers to measure multiple cardiac signals at once to understand how they interact to control heart function.

0 Comments

image: Opinion: The Precarious Earth

Opinion: The Precarious Earth

By | June 18, 2012

People are currently driving the planet on a crash course with global stability. Something must be done.

39 Comments

image: Opinion: What’s Wrong with COI?

Opinion: What’s Wrong with COI?

By | June 12, 2012

Financial “conflicts of interest” should not be so quickly condemned. Industry relationships are unequivocally beneficial.

0 Comments

image: Opinion: Justice Delayed, Health Denied

Opinion: Justice Delayed, Health Denied

By | June 4, 2012

African justice systems must change to help curb HIV and tuberculosis transmission in prisons.

12 Comments

image: Active Brains Help Heal Paralysis

Active Brains Help Heal Paralysis

By | May 31, 2012

Engaging the brain with cognitive tasks helps paralyzed rats walk again.

4 Comments

image: Next Generation: The Brain Bot

Next Generation: The Brain Bot

By | May 29, 2012

A 30-year-old technique to record the electrical activity of neurons gets a robotic makeover.

0 Comments

Opinion: Pressured to Commercialize

By | May 28, 2012

Is the push for science to save the still flailing economy a threat to scientific research?

5 Comments

image: Next Generation: Good Vibrations

Next Generation: Good Vibrations

By | May 23, 2012

Adding texture to a lotus-leaf-like surface lets researchers control the movement of liquid droplets, and provides a cheap alternative for microfluidic applications.

1 Comment

image: Opinion: Saving Species through Economics

Opinion: Saving Species through Economics

By | May 21, 2012

Successful conservation depends on an economy that doesn’t incentivize destruction of species and habitats.

4 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Decoding the Tripping Brain
  3. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS